133 related articles for article (PubMed ID: 21592819)
41. Characterization of cDNA and genomic sequences encoding a canine chemokine receptor, CXCR4 and its ligand CXCL12.
Tsuchida S; Kagi A; Takahashi T
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):219-25. PubMed ID: 17316828
[TBL] [Abstract][Full Text] [Related]
42. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
[TBL] [Abstract][Full Text] [Related]
43. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
[TBL] [Abstract][Full Text] [Related]
44. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
45. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
46. Estrogen receptor alpha gene polymorphism and breast cancer.
Siddig A; Mohamed AO; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():95-107. PubMed ID: 18837889
[TBL] [Abstract][Full Text] [Related]
47. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
48. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS
J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880
[TBL] [Abstract][Full Text] [Related]
49. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
50. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
[TBL] [Abstract][Full Text] [Related]
51. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
52. Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I alleles) in the Polish population.
Lewandowska M; Franciszkiewicz K; Prokop J; Ofori H; Jagodzinski PP
J Hum Genet; 2002; 47(11):585-9. PubMed ID: 12436194
[TBL] [Abstract][Full Text] [Related]
53. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
[TBL] [Abstract][Full Text] [Related]
54. Association of the SDF1-3'A polymorphism with susceptibility to myocardial infarction in Chinese Han population.
Luan B; Han Y; Zhang X; Kang J; Yan C
Mol Biol Rep; 2010 Jan; 37(1):399-403. PubMed ID: 19821058
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the stromal cell-derived factor 1-3'A gene polymorphism in pancreatic cancer.
Theodoropoulos GE; Panoussopoulos GS; Michalopoulos NV; Zambirinis CP; Taka S; Stamopoulos P; Gazouli M; Zografos G
Mol Med Rep; 2010; 3(4):693-8. PubMed ID: 21472301
[TBL] [Abstract][Full Text] [Related]
56. The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer.
Kontogianni P; Zambirinis CP; Theodoropoulos G; Gazouli M; Michalopoulos NV; Flessas J; Liberi M; Zografos GC
Mol Biol Rep; 2013 Jan; 40(1):43-50. PubMed ID: 23129313
[TBL] [Abstract][Full Text] [Related]
57. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
[TBL] [Abstract][Full Text] [Related]
58. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
[TBL] [Abstract][Full Text] [Related]
59. Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population.
Petersen DC; Glashoff RH; Shrestha S; Bergeron J; Laten A; Gold B; van Rensburg EJ; Dean M; Hayes VM
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):521-6. PubMed ID: 16284526
[TBL] [Abstract][Full Text] [Related]
60. Potential Protective Role of SDF-1 and CXCR4 Gene Variants in the Development of Dementia.
Dalan B; Timirci-Kahraman O; Gulec-Yilmaz S; Altinkilic EM; Duman S; Ayhan H; Isbir T
Psychiatr Danub; 2020; 32(1):92-96. PubMed ID: 32303038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
